Nextcell Pharma Ab Is A Swedish Biopharmaceutical Company Based In Huddingefounded In 2014The Company Specializes In Drug Development And Stem Cell Bankingfocusing On Mesenchymal Stromal Cells Derived From Umbilical Cord Tissuenextcell Is Dedicated To Developing Cell Therapies For Autoimmune And Inflammatory Diseasesparticularly Type 1 Diabetes The Company Offers Protransa Drug Candidate Aimed At Preserving Insulin Producing Capacity In Patients With Type 1 Diabeteswhich Has Shown Safety And Efficacy In Clinical Trialsadditionallynextcell Operates Cellavivascandinaviaae S Largest Private Stem Cell Bankproviding Storage For Umbilical Cord Blood And Tissuethe Company Collaborates With Institutions Like Karolinska Institutet And Employs A Proprietary Selection Algorithm To Enhance The Potency Of Mesenchymal Stromal Cells For Therapeutic Applicationsnextcell Is Led By Ceo Drmathias Svahn And Has A Team Of 24 Staff Membersit Is Publicly Traded On Nasdaq Stockholm Under The Ticker Nxtcl
No conferences found for this company.
| Company Name | Nextcell Pharma Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
